Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers March 30, 2015
Pharmacy Choice - March 2015 Newsletter - March 30, 2015

Pharmacy Choice Newsletter - March 2015

The Pharmacy Spotlight - March 2015
March 5, 2015
Volume 17, Issue 3
Forward to a Friend
News Pharmacy Careers Resources Education Business Marketplace Login
This newsletter is sponsored by:
Indian Health Virtual Career Fair: March 31st
Industry Headlines
02/26 – Optimizing EHRs for Better Patient Outcomes
02/26 – Baptist Orange Hospital to halt in-patient care
02/26 – NCI -St. Jude researchers find that an inherited gene variation leaves young leukemia patients at risk for peripheral neuropathy
02/26 – FDA Accepts Priority Review of Rapamune for Treatment of Lymphangioleiomyomatosis
FDA Resources
Generic Drug Approvals
Paragraph IV Patent Certifications
News Releases
Upcoming Meetings
Office of Generic Drugs
FDA Drug Shortages

Quick Poll
The availability of a reliable, rapid reversal agent for Factor-Xa antagonists would result in Factor Xa antagonists replacing warfarin for DVT treatment:
Strongly agree
Neutral or uncertain
Strongly disagree

Want to fill out the poll?
Hot Pharmacy Jobs
Available Opportunities Nationwide!
Indian Health Service
Nationwide, AA
Indian Health Service
Pharmacy Manager (Spring Valley NY)
Spring Valley, NY
Los Angeles, CA
Full-time Float Pharmacist - Central and Southern Oregon
Albertsons Pharmacies
Eugene, OR
Albertsons Pharmacies
Inpatient Pharmacists Needed!
Rx Pro Health
Longview, WA

Choose from Pharmacy Jobs Nationwide with Rx Pro Health. Apply Now!
March Disease Focus
Influenza 2015 Update: Matchmaker, matchmaker…what happened?
by Alan P. Agins, Pharmacologist, PhD
Late in 2014, we got news that the most prevalent circulating influenza virus strain this season, H3N2 (A/Switzerland/9715293/2013), was antigenically different from the H3N2 strain that was used to produce this year's vaccine. Depending on the source from who one first heard this news, the sentiments ranged from the cynical: "the vaccine is totally ineffective", doesn't work, is a waste of time and money … Read More
Hot Topic
FDA Approves Apixaban for DVT & PE
Darrell Hulisz, RPh, PharmD, Associate Professor, CWRU, School of Medicine and
Jason Mersek Doctor of Pharmacy Candidate, ONU College of Pharmacy

Apixaban (Eliquis) is a new oral anticoagulant that inhibits Factor Xa, similar to fondaparinux. Through the ARISTOTLE trial, Apixaban was found to be superior to warfarin for the prevention of stroke in patients with atrial fibrillation. Recently, apixaban was approved by the FDA for acute treatment, and long-term preventions … Read More
Last Month's Poll
Over the next 5-10 years, do expect oral Factor Xa inhibitors, such as rivaroxaban & edoxaban to replace warfarin?
Yes- 38.6%
No - 49.7%
Uncertain - 11.6%
Continuing Education for Pharmacy Professionals
Enroll now at for the latest online Live and Enduring Continuing Education.
Inexpensive, easy to access, and excellent content all define the RxSchool Live experience!
Live On-line Webinars
Atrial Fibrillation Treatment in Older Adults
Tuesday, March 10, 2015 - 7:00 PM ET, 2.0 credit hours
Update on Cholesterol Lowering Therapy
Wednesday, March 11, 2015 - 6:00 PM ET, 1.0 credit hour
ADHD in Children & Adults: Etiology, Pathology, Pharmacotherapy
Thursday, March 12, 2015 - 12:00 PM ET, 2.0 credit hours
RxSchool is accredited by the Accreditation Council for Pharmacy
Education as a provider of continuing pharmacy education.
Featured distance
Drug Therapy Management Series Part II: Psychiatric Disorders
ACPE Pharmacist UPN#: 0372-0000-14-006-H01-P
ACPE Technician UPN#: 0372-0000-14-006-H01-T
Credits: 5 credit hours
Release Date: April 8, 2014
Expiration Date: April 8, 2017
Fee: $40.00
Audience: Pharmacists, Pharmacy Technicians
For more information,
visit the Course Information Page
RxSchool is accredited by the Accreditation Council for Pharmacy
Education as a provider of continuing pharmacy education.

©2014 Pharmacy Choice (PC) - All rights reserved.
425 S. Cherry St. Suite 200 | Denver, Colorado 80246
Important Notice: The information contained in this newsletter is intended as an informational resource only. View our full disclaimer.
Previous Newsletters
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014

Be seen by thousands of industry eyes.
Advertise in the Pharmacy Choice Newsletter.

Websites »
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement